American Century Companies’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-72,508
| Closed | -$108K | – | 2685 |
|
|
2022
Q4 | $108K | Sell |
72,508
-323,238
| -82% | -$482K | ﹤0.01% | 2444 |
|
|
2022
Q3 | $1.48M | Sell |
395,746
-177,412
| -31% | -$665K | ﹤0.01% | 1549 |
|
|
2022
Q2 | $2.84M | Buy |
573,158
+38,494
| +7% | +$191K | ﹤0.01% | 1311 |
|
|
2022
Q1 | $4.39M | Buy |
534,664
+114
| +0% | +$936 | ﹤0.01% | 1142 |
|
|
2021
Q4 | $5.39M | Buy |
534,550
+17,358
| +3% | +$175K | ﹤0.01% | 1033 |
|
|
2021
Q3 | $8.2M | Buy |
517,192
+114,438
| +28% | +$1.81M | 0.01% | 901 |
|
|
2021
Q2 | $9.58M | Buy |
+402,754
| New | +$9.58M | 0.01% | 828 |
|